Dosimetry and optimal scan time of (18F)SiTATE-PET/CT in patients with neuroendocrine tumours
Radiolabelled somatostatin analogues targeting somatostatin receptors (SSR) are well established for combined positron emission tomography/computer tomography (PET/CT) imaging of neuroendocrine tumours (NET). [18F]SiTATE has recently been introduced showing high image quality, promising clinical per...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
29 April 2021
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2021, Volume: 48, Pages: 3571-3581 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-021-05351-x |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00259-021-05351-x |
| Author Notes: | Leonie Beyer, Astrid Gosewisch, Simon Lindner, Friederike Völter, Lena M. Mittlmeier, Reinhold Tiling, Matthias Brendel, Clemens C. Cyran, Marcus Unterrainer, Johannes Rübenthaler, Christoph J. Auernhammer, Christine Spitzweg, Guido Böning, F. J. Gildehaus, Klaus Jurkschat, Carmen Wängler, Björn Wängler, Ralf Schirrmacher, Vera Wenter, Andrei Todica, Peter Bartenstein, Harun Ilhan |
| Summary: | Radiolabelled somatostatin analogues targeting somatostatin receptors (SSR) are well established for combined positron emission tomography/computer tomography (PET/CT) imaging of neuroendocrine tumours (NET). [18F]SiTATE has recently been introduced showing high image quality, promising clinical performance and improved logistics compared to the clinical reference standard 68Ga-DOTA-TOC. Here we present the first dosimetry and optimal scan time analysis. |
|---|---|
| Item Description: | Published online: 29 April 2021 Im Titel ist die Zahl "18" hochgestellt, der Ausdruck "18F" steht in eckiger Klammer Gesehen am 14.12.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-021-05351-x |